Neuroblastoma: Molecular Insights and Clinical Implications
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: 15 May 2025 | Viewed by 2183
Special Issue Editor
Special Issue Information
Dear Colleagues,
Neuroblastoma has long frustrated clinicians as it is a very heterogeneous, oftentimes aggressive cancer of childhood. It is the most common non-brain solid tumor in children, and the survival remains under 70% for most patients. Therefore, physician scientists as well as bench scientists have long sought to understand this disease in order to find better targeted therapies. The articles in this issue will focus on some of the newer treatment modalities that go beyond traditional chemotherapies and include immunotherapies and small molecule therapies. This issue is dedicated to showcasing some of the most up-to-date developments in the field. The hope is that by understanding the molecular mechanisms of neuroblastoma, we will find new targets for therapy and improve survival in children with this tumor.
Dr. Mary Beth Madonna
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuroblastoma
- molecular mechanisms
- targeted therapies
- immunotherapies
- small molecule therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.